Schmitt, M;Sturmheit, AS;Welk, A;Schnelldorfer, C;Harbeck, N.Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA..Methods Mol Med.2006.120.245-65

Morrison, JE;Jacobs, VR.Classic intrafascial supracervical hysterectomy (CISH): 10-year experience..JSLS.2006.10.1.26-9

Jacobs, VR;Morrison, JE.Application of a locally placed anesthesia catheter for reduction of postoperative pain after mastectomy for breast cancer..Int J Fertil Womens Med.2006.51.5.225-9

Stemmler, J;Schmitt, M;Willems, A;Bernhard, H;Harbeck, N;Heinemann, V.Brain metastases in HER2-overexpressing metastatic breast cancer: Comparative analysis of trastuzumab levels in serum and cerebrospinal fluid..J Clin Oncol.2006.24.18.64S-64S

Artmann, A;Heyne, M;Kiechle, M;Harbeck, N.Breast self examination training and counseling as motivation strategies for breast awareness and participation in breast cancer screening programs..J Clin Oncol.2006.24.18.55S-55S

Thussbas, C;Nährig, J;Streit, S;Bange, J;Kates, R;Ulm, K;Kiechle, M;Hoefler, H;Ullrich, A;Harbeck, N.FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer..J Clin Oncol.2006.24.18.34S-34S

Llombart-Cussac, A;Martin, M;Harbeck, N;Anghel, R;Eniu, A;Melemed, A;Clark, R;Simms, L;Kaiser, C;Ma, D.Randomized, phase II study of two doses of pemetrexed as first-line chemotherapy for locally advanced or metastatic breast cancer (MBC): Clinical results and exploratory pharmacogenomic analysis..J Clin Oncol.2006.24.18.140S-140S

Kiechle, M;Meindl, A.Hereditary breast and ovarian cancer.Geburtsh Frauenheilk.2006.66.6.545-548

Kates, R;Allgayer, H;Harbeck, N.Hierarchical neural net technology for molecular staging with clinical data.Eur J Cancer.2006.4.6.9-9

Schmitt, M;Harbeck, N;Foekens, J;Maier, S.DNA-methylation markers and YB-1 as indicators of therapy response in breast cancer.Eur J Cancer.2006.4.6.11-12